Synthesis and biological evaluation of (4-Fluorophenyl)(1-(5-phenyl-1,3,4-oxadiazol-2-yl)indolizin-3-yl)methanone derivatives as anticancer and antimicrobial agents
Abstract
A novel series of (4-Fluorophenyl (1-(5-phenyl-1,3,4-oxadiazol-2-yl)indolizin-3-yl)methanone derivatives 9(a-n) were synthesized by the coupling reaction of 3-(4-fluorobenzoyl)indolizine-1-carboxylic acid and substituted benzohydrazide followed by intramolecular cyclization. The structures of the compounds were characterized by 1H NMR, 13C NMR, LCMS, FT-IR, and elemental analyses. The compounds 9(a-n) anti-cancer activity was evaluated against the MCF-7 cell line (HTB-22, Homo sapiens, Breast carcinoma). Compound 9j (IC50 = 21.57 μM), and 9n (IC50 = 8.52 μM) exhibited the most potent cytotoxicity activity compared with standard drug doxorubicin (IC50= 25.71). The antibacterial activity was evaluated against Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 8739. The compounds ZOI=16mm) and 9i (ZOI=18 mm) exhibited moderate antibacterial activity compared with standard drug ciprofloxacin. The antifungal activity was evaluated against Candida albicans ATCC 10231. Most compounds exhibited moderate antifungal activity compared with the standard drug Itraconazole.
Keywords:
Indolizines, 1,3,4-Oxadiazole, Anticancer, Antibacterial activity, Antifungal activityDOI
https://doi.org/10.25004/IJPSDR.2022.140102References
Sadowski B, Klajn J, Gryko DT. Recent advances in the synthesis of indolizines and their π-expanded analogues. Org Biomol Chem. 2016; 14:7804 -7828.
Kuntz DA, Nakayama S, Shea K, Hori H, Uto Y, Nagasawa H, Rose DR. Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II. Chem Biochem. 2010; 11:673-680.
Niu T, Huang L, Wu T, Zhang Y. FeCl3-promoted alkylation of indoles by enamides. Org Biomol Chem. 2011; 9: 273-277.
Coldham I, Jana S, Watson L, Martin NG. Cascade condensation, cyclization, intermolecular dipolar cycloaddition by multi-component coupling and application to a synthesis (±) crispine A. Orga Biomol Chem. 2009; 7:1674-1679.
Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity Bioorg Med Chem. 2017; 25:4424-4432.
Arvin-Berod M, Desroches-Castan A, Bonte S, Brugière S, Couté Y, Guyon, L, Jean-Jacques F, Isabelle Baussanne B, Demeunynck M. Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Anti-angiogenic Drugs. ACS Omega, 2017; 2:9221–9230.
Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA. Tylophorine, a Phenanthraindolizidine alkaloid isolated from Tylophora indica exerts anti-angiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesis. Mol cancer. 2013; 12:1-16.
Boot A, Brito1 A, Wezel TV, Morreau H, Costa M, Proença F. Anticancer Activity of Novel pyrido[2,3-b]indolizine Derivatives: The Relevance of Phenolic Substituents. Anticancer Research. 2014; 34:1673-1678.
De Fatima Pereira M, Rochais C, Dallemagne P. Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities. Anti-Cancer Agents in Med Chem. 2015; 15:1080-1091.
Sandeep C, Venugopala KN, Gleiser RM, Chetram A, Padmashali B, Kulkarni RS, Venugopala R, Odhav B, Greener synthesis of indolizine analogue using water as a base and solvent: Study for larvicidal activity against Anopheles arabiensis. Chem Biology & Drug Design, 2016; 88:899-904.
Sandeep C, Venugopala KN, Khedr MA, Padmashali B, Kulkarni RS, Venugopala R, Odhav B. Design and Synthesis of Novel Indolizine Analogues as COX-2 Inhibitors: Computational Perspective and in vitro Screening. Ind J Pharma Education and Research. 2017; 51:452-460.
Gundersen LL, Charnock C, Negussie A.H, Rise F, Teklu S. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. European J Pharm Sciences. 2007; 30:26-35.
Flitsch W. Pyrroles with Fused Six-membered Heterocyclic Rings: (i) a-Fused. Comprehensive Heterocyclic Chemistry. 1984; 443-495.
Flitsch W. Fused Five- and Six-membered Rings with Ring Junction Heteroatoms. Comprehensive Heterocyclic Chemistry II. 1996; 237-248.
Ghinea IO, Dinica RM. Breakthroughs in Indole and Indolizine Chemistry – New Synthetic Pathways, New Applications. Org Pharma Perspective. 2016; 115-142
Nagaraj, Chaluvaraju KC, Niranjan MS, kiran S. 1, 3, 4 oxadiazole: a potent drug candidate with various pharmacological activities. International J Pharmacy and Pharma Sciences. 2011; 3:9-16.
De Oliveira CS, Lira BF, Barbosa-Filho JM, Lorenzo JGF, de Athayde- Filho PF. Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000-2012. Molecules.2012; 17:10192-10231.
Gurupadaswamy HD, Girish V, Kavitha CV, Raghvan SC, Khanum SA. Synthesis and evaluation of 2, 5-di(4-aryloylaryloxymethyl)- 1,3,4-oxadiazoles as anti-cancer agents. European J Med Chem. 2013; 63:536-543.
Agarwal M, Singh V, Sharma SK, Sharma P, Ansari MY, Jadav SS, Ahsan MJ. Design and synthesis of new 2, 5-disubstituted-1, 3, 4-oxadiazole analogues as anti-cancer agents. Med Chem Research. 2016; 25:2289-2303
Kandemir H, Ma C, Kutty SK, Black DS, Griffith R, Lewis PJ, Kumar N. Synthesis and biological evaluation of 2,5-di(7-indolyl)-1,3,4- oxadiazoles, and 2- and 7-indolyl 2-(1,3,4-thiadiazolyl)ketones as antimicrobials. Bioorg Med Chem. 2014; 22:1672-1679.
Franski R. Biological act ivit ies of the compound Bearing 1,3,4-Oxa(thia)diazole ring: A Review. Asian J Chem. 2005; 17:2063- 2075.
Anjali B, Sowmyasree K, Archana A, Shweta B, Saritha P, Bhagvan Raju M. Synthesis and evaluation of some novel heterocyclic compounds containing an oxadiazole moiety. GSC Bio Pharma Sciences. 2019; 06: 9-20.
Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. Journal of Immunol Methods. 1993; 160: 81-88.
Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol in Vitro. 2001; 15:257-259.
Hussain RM, Nouri AME, Oliver RTD. A new approach for measurement of cytotoxicity using Colorimetric assay. J Immunol Methods. 1993; 160:89-96.
He Y, Zhu Q, Chen M, Huang Q, Wang W, Li Q, Huang Y, Di W. The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT Assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget, 2016; 7: 70803-70821.
Bergeron MG, Brusch JL, Barza M, Weinstein L. Bactericidal Activity and Pharmacology of Cefazolin. Antimicrobial Agents and Chemotherapy. 1973; 4:396-401.
Eagle H. The rate of bactericidal action of penicillin in vitro as a function of its concentration and its paradoxically reduced activity at high concentrations against certain organisms. Journal of Experimental Medicine. 1948; 88:99-131.
Collins CH. Lynes P, Grange JM. National Committee for Clinical Laboratory Standards method. Microbial Methods. 8th edition. 2004; 175-190.
Nayan R. Bhalodia, Shukla VJ. Antibacterial and antifungal activities from leaf extracts of Cassia fistula l: An ethnomedicinal plant. J advanced Pharma technology and research. 2011; 2:104-109.
Mummed B, Abraha A, Feyera T, Nigusse, A, Assefa S. In Vitro Antibacterial Activity of Selected Medicinal Plants in the Traditional Treatment of Skin and Wound Infections in Eastern Ethiopia. BioMed Research International, 2018; 1-8.
Published
Abstract Display: 635 
PDF Downloads: 695 
